MRK

Merck Stock Price

78.34
0.56 (0.72%)
Upgrade to Real-Time
Afterhours (Closed)
78.34

Low
71.715

52 Week Range

High
87.80

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type
Merck and Co Inc MRK NYSE Common Stock
  Price Change Change Percent Stock Price Last Traded
0.56 0.72% 78.34 19:38:38
Open Price Low Price High Price Close Price Prev Close
77.81 77.81 78.66 78.41 77.78
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
81,774 11,643,369 $ 78.25 $ 911,092,879 11,156,506 71.715 - 87.80
Last Trade Time Type Quantity Stock Price Currency
19:56:24 65 $ 78.32 USD

Merck Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 198.30B 2.53B 2.53B $ 48.00B $ 7.05B 2.77 27.00
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ 2.48 3.17% 274.58k 0.10%

more financials information »

Merck News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical MRK Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week73.5878.6673.4876.3413,485,3604.766.47%
1 Month75.5179.4972.8576.6211,700,4852.833.75%
3 Months74.7279.4971.71575.8412,368,7923.624.84%
6 Months84.9485.6071.71577.7610,905,424-6.60-7.77%
1 Year77.0087.8071.71578.839,860,0191.341.74%
3 Years57.7792.6456.25577.8210,086,99620.5735.61%
5 Years53.5792.6452.8371.159,798,42924.7746.24%

Merck Description

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, close to 40% of the firm's sales are generated in the United States.


Your Recent History
NYSE
MRK
Merck
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.